EAACI Digital Congress 2020 - Final Programme - European Academy of Allergy and Clinical Immunology
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
European Academy of Allergy
and Clinical Immunology
6 – 8 June 2020
EAACI Digital
Congress 2020
- Final Programme -
EAACI.org #eaaci2020EAACI Digital Congress 2020 Content
Bridging innovations into allergy and asthma prevention Welcome messages............................................................ 4 Programme at a Glance - June 6.................................. 23
EAACI Committees............................................................ 6 Programme at a Glance - June 7.................................. 28
Welcome to EAACI Digital Congress 2020!
General information........................................................... 8 Programme at a Glance - June 8.................................. 33
Under the timely motto “Bridging innovations into Allergy and Asthma Prevention”, we are offering you the opportunity to EAACI future events.......................................................... 10 Speaker index...................................................................... 38
explore our rich scientific programme in a truly innovative way. What better way to be updated on the conceptual and technological
Ceremonies.......................................................................... 15 National Society Village................................................... 40
advances in our field, than by taking part in a brand-new technological approach to our EAACI Annual Congress?
Fellowship Winners............................................................. 15 Sponsorship and Exhibition............................................. 42
During the Congress you will be able to: EAACI Fellows 2020......................................................... 16 Company Sponsored Symposia..................................... 46
EAACI Awards 2020........................................................ 17 Exhibitor & Sponsor List................................................. 54
• Tune in and watch a variety of virtual sessions in your own time and without missing out;
• Discuss important topics and ask your questions via an interactive Q&A; EAACI Activity Challenge................................................. 20 Exhibitor & Sponsor Editorials....................................... 56
• Consult our vast number of abstracts, posters and webcast symposia with novel research any time during the congress period; Description of Session Types......................................... 21
In order to match this digital format, we have split our Scientific Programme in 3 parts:
Addresses
A selection of the most exceptional sessions, to be
Live Scientific
delivered to you from June 6 to 8. You will find the details
Programme
of this programme from pages 23 to 36. EAACI Headquarters EAACI Digital Congress 2020 General Enquiries
Hagenholzstrasse 111 Online Platform congress@eaaci.org
3rd Floor https://virtual.eaaci.org/
Industry All the valuable content brought to you by our sponsors 8050 Zurich
Programme and exhibitors. Switzerland
EAACI Technical Support Congress Registration
Tel: +41 44 205 55 33
support@eaaci.org registration@eaaci.org
info@eaaci.org
www.eaaci.org
All the content originally included in the Scientific Programme
Recorded Scientific
prepared for the EAACI Congress 2020 in London:
Programme
• Symposia (SYM)
• Interactive Symposia (ISYM) and Workshops (IWS)
• Hot Topics (HT)
• Year in Review (YIR)
• Interactive Postgraduate Courses (IPGC)
• Pro & Cons (P&C)
• Ethics Sessions (ES)
• Sister Society Symposia (SSS)
• Late-Breaking Oral Abstract Sessions (LB OAS)
• Late-Breaking Poster Discussion Sessions (LB PDS)
• Late-Breaking Thematic Poster Sessions (LB TPS)
• Oral Abstract Sessions (OAS)
• Poster Discussion Sessions (PDS)
• Thematic Poster Sessions (TPS)
A selection of the content will be available
for 6 months after the Congress.
2 3BECOME
Welcome messages
AN EAACI
MEMBER
Over 12,000
Bridging innovations into allergy and asthma prevention
professionals are already
It is my great pleasure to invite you to the first ever digital EAACI Annual Congress
2020, which will be held from 6 to 8 June.
members of the largest
medical association
In the next few years, medical innovations will fundamentally revolutionize the
healthcare system, with the goal of improving peoples’ quality of life. This year’s
Congress motto suggests that we will not only present state-of-the-art knowledge of Allergy and Clinical
in allergy and clinical immunology but will go beyond this, bridging it with the most Immunology.
contemporary, inspiring and creative processes and ideas diffused and adapted to
the needs of our patients.
Modern times also foster the revival of the old definition of innovation as a synonym
for rebellion or revolt. Change is not only about embracing new ideas but also about
leaving outdated ones behind, and what better opportunity to do so than taking part
in this completely new format of Annual Congress?
Do not miss the chance to take part in the modern allergology paradigm shift driven by new discoveries: endotype and theratype
approaches that change not only the taxonomy but the way we perceive and manage the allergic disease. The interactive sessions
and discussions designed to match the expectations of all participants will provide a platform to stimulate the creativity of thou- Benefits applied to all categories
sands of delegates, and the high-throughput screening of viable solutions using the innovative digital format.
Join us at the EAACI Congress 2020!
Free subscription to online Allergy and PAI journals Possibility to join Task Forces
Marek Jutel
EAACI President 2019-2021 Full voting rights & eligibility for election 50% Discount EAACI Knowledge Exam
See you all online for the EAACI Digital Annual Congress!
On behalf of the Local Organising Committee, it is with great pleasure to invite you Full Junior Membership EAACI / NAS
to the EAACI Annual Congress 2020, which this year will take part digitally from Membership (under 36 years old) Dual Membership
6- 8 June.
Our world is everchanging, and with the advent of new technologies in medicine: om-
ics, big data, mHealth and the development of artificial intelligence among others,
this congress will provide a unique opportunity to foster and discuss these avenues
150€* Free 30€
in our field. The future includes tackling allergic diseases and asthma at their root,
EAACI Annual Congress EAACI Annual Congress EAACI Focused Meetings
and these discoveries will be powerful tools to work towards prevention in our field.
Up to 25% discount Up to 55% discount 25% discount
You will be able to explore the same quantity and quality of scientific content that EAACI Focused Meetings EAACI Focused Meetings EAACI Schools & Master Classes
you would have experienced during our traditional Congress in London - while 25% discount Up to 70% discount Up to 40% discount
staying safe at home and benefiting financially.
EAACI Schools & Master Classes EAACI Schools & Master Classes Printed subscriptions for Allergy &
Besides full access to the Digital Congress content, including Keynote symposia , state-of -the -art symposia, industry symposia, Up to 40% discount Up to 50% discount PAI is an additional 60€ per year
oral and poster presentations – you will also benefit from access to these resources for 6 months after the event. Elegibility for EAACI fellowships
Subscription to printed journals
(upon request) & Scholarships This membership only applies to
We look forward to welcoming you to this new format of EAACI Congress where we will push boundaries with forward thinking and
novel approaches to preventing allergy and asthma worldwide. Elegibility for EAACI events members of National Societies who
* For members from countries travel grants have signed the EAACI NAS Dual
Mohamed Shamji with a GNP of less than USD Membership Agreement. Check our
Printed subscriptions for Allergy &
EAACI Digital Congress 2020 Chair 10,000: Full Membership is 75€ National Societies Agreements list
PAI is an additional 60€ per year
and EAACI Allied Health Interest at www.eaaci.org/membership
Group Membership is 40€.
4 Discover our full membership offer at EAACI.org/membership or send an email to member@eaaci.orgEAACI Committees EAACI Committees
EAACI Executive Committee Scientific Programme Committee (SPC)
EAACI Board of Officers EAACI Interest and Working Group Representatives Scientific Programme Committee 2020 Interest Group Chairs 2017 – 2019
Marek Jutel, President Jolanta Walusiak-Skorupa Mohamed Shamji, Scientific Programme Committee Chair 2018-2020 Margitta Worm, Food Allergy
Jürgen Schwarze, Secretary General Oscar Palomares Mohamed Shamji, EAACI Congress 2020 Chair Marina Atanaskovic-Markovic, Drug Allergy
Liam O’Mahony, Treasurer Marek Jutel, EAACI President 2019-2021 Lars, Jacobsen, Allergen Immunotherapy
Edward Knol, Vice-President Congresses Members at Large Ioana Agache, EAACI Past President 2017-2019 Monika Raulf, Environmental and Occupational Allergy
Stefano del Giacco, Vice-President Education & Specialty Jürgen Schwarze, EAACI Secretary General 2019-2021 Paolo Matricardi, Allergy Diagnosis & Systems Medicine
Oliver Pfaar
Karin Hoffmann-Sommergruber, Vice-President Communications Edward Knol, EAACI VP Congresses 2019-2021 Elizabeth Angier, Allied Health & Primary Care
Maria Torres
& Membership Carsten Schmidt-Weber, EAACI VP Congresses 2017-2019
Isabel Skypala
Tomás Chivato, Vice-President Science Tomas Chivato, EAACI VP Science 2019-2021 Working Group Chairs 2019 – 2021
Antti Lauerma
Ioana Agache, Past President Helen Brough, EAACI Congress 2020 Co-Chair
Markus Ollert Anna Sediva, Immunodeficiencies
Nasser Shuaib, EAACI Congress 2020 Co-Chair
Asli Gelincik Wojciech Feleszko, Infections
Liam O’Mahony, EAACI Congress 2020 Co-Chair
Thomas Eiwegger, Biologicals
Luis Delgado, EAACI Congress 2019 Chair
EAACI Section Chairpersons Maia Rukhadze, Allergy, Asthma & Sport
Banu Bozkurt, Ocular Allergy
Matteo Bonini, Asthma Section Section Secretaries 2019 – 2021
Antonella Cianferoni, Eosinophilic Eosophagitis
Charlotte Mortz, Dermatology Section
Milena Sokolowska, Basic & Clinical Immunology Gunter Sturm, Insect Venom Hypersensitivity
Ludger Klimek, ENT Section
Ibon Eguiluz-Gracia, Asthma Grzegorz Brozek, Epidemiology
Eva Untersmayr-Elsenhuber, Basic & Clinical
Stefania Arasi, Pediatrics Carmen Galan, Aerobiology & Air Pollution
Immunology Section
Barbara Ballmer-Weber, Dermatology Maria Escribese, Genomics & Proteomics
Helen Brough, Pediatrics Section
Sanna Toppila-Salmi, ENT Isabella Pali-Schöll, Comparative Veterinary Allergology
Carmen Riggioni, Junior Members Section
Pasquale Combierati, JM Assembly Audrey Dunn Galvin, Allied Health
Radoslaw Gawlik, Allied Health and
Rosan Meyer, Allied Health & Primary Care Elizabeth Angier, Primary Care
Primary Care Section
Working Group Chairs 2017 - 2019
Section Secretaries 2017 – 2019
Isabella Quinti, Immunodeficiencies
Local Organising Committee (LOC) Eva Untersmayr-Elsenhuber, Basic & Clinical Immunology
Hermelijn Smits, Infections
Matteo Bonini, Asthma
Oscar Palomares Gracia, Biological
Lauri-Ann Van der Poel, Pediatrics
Mohamed Shamji, EAACI Digital Congress 2020 Chair Jonathan Hourihane Clare Lloyd Mariana Couto, Allergy, Asthma & Sport
Charlotte Mortz, Dermatology
Helen Brough, EAACI Digital Congress 2020 Co-Chair Shelley Dua Paul Lavender Jean-Luc Fauquert, Ocular Allergy
Ludger Klimek, ENT
Liam O’Mahony, EAACI Digital Congress 2020 Co-Chair Hassan Arshad Catherine Hawrylowicz Ingrid Terreehorst, Eosinophilic Eosophagitis
Alberto Alvarez-Perea, JM Assembly
Shuaib Nasser, EAACI Digital Congress 2020 Co-Chair Ian Adcock Hanneke Oude Elberink , Insect Venom Hypersensitivity
George du Toit Jon Genuneit, Epidemiology
Stephen Durham Interest Group Chairs 2019 – 2021
Nicola Brathwaite Michel Thibaudon, Aerobiology & Air Pollution
Adam Fox Alexandra Santos, Food Allergy Cornelis M. Van Drunen, Genomics & Proteomics
Glenis Scadding
Clive Grattan Marina Atanaskovic-Markovic, Drug Allergy Jozef Janda, Comparative Veterinary Allergology
Madison Lenormand
Isabel Skypala Montserrat Alvaro Lozano, Allergen Immunotherapy James Gardner, Allied Health
Roisin Fitzsimons
Adnan Custovic Mohamed Jeebhay, Environmental and Occupational Allergy Radoslaw Gawlik, Primary Care
Paul Turner
Fan Chung Bernadette Eberlein, Allergy Diagnosis & Systems Medicine
Tabi Leslie
Rebecca Knibb
Sebastian Johnston
6 7General information General information
About EAACI no Scholarships for the EAACI Digital exhibition will be open according to Poster Exhibition Information videos to be publicly shared are pro- desktops, iPad/tablets, and mobile
Congress 2020. Nevertheless, we are the main scientific programme timeta- hibited. phones. However it is recommend to
The European Academy of Allergy pleased to make the Digital Congress ble, subject to final adjustments. • Thematic Poster Sessions (TPS): use computers, to get the best expe-
and Clinical Immunology (EAACI) is a registration free of charge for Junior TPS can be found in the e-poster sec- Press contact details rience including live chat during ses-
non-profit organisation active in the Start of Virtual Exhibition: tion of the Digital Congress, together
Members. EAACI Public Affairs Specialist: sions within the Live Scientific Pro-
field of allergic and immunologic dis- 6 June 2020 – 9:00 (CET) with a voice-over, and will be available Chiara Hartmann. gramme, an important feature that
eases such as asthma, rhinitis, ecze- End of Virtual Exhibition: in the EAACI Media Library. Office number: +41 44 205 55 34 boosts interaction between you, facul-
ma, occupational allergy, food and Disclaimer 6 December 2020 – 17:30 (CET) • Poster Discussion Sessions (PDS): Email: chiara.hartmann@eaaci.org ty and your peers. In regards to a pref-
drug allergy and anaphylaxis. Participants are encouraged to pur- PDS can be found in the e-poster sec- erable web browser, we suggest Goog-
General Assembly
EAACI was founded in 1956 in Flor- chase an insurance to cover loss in- tion of the Digital Congress, together Registration le Chrome as the most compatible one.
ence and has become the largest med- curred in the event of cancellation. EAACI’s General Assembly will take with a voice-over, and will be available In order to provide a well streamlined
ical association in Europe in the field in the EAACI Media Library. Registration fee for delegates includes
EAACI cannot be held liable for any place remotely during the EAACI Dig- support, we kindly ask you to send any
of allergy and clinical immunology. It • Digital Congress Poster Display full access to the EAACI Digital Con-
hindrance or disruption of the EAACI ital Congress 2020 on Monday 08 technical queries directly to following
includes over 12‘000 members from (DCPD): DCPD can be found in the gress 2020 content including plenary
Digital Congress 2020 proceedings June, 08:00-09:00 CET. The Gen- email address: support@eaaci.org.
120 countries, as well as over 75 e-poster section during the Digital Congress. talks, symposia, workshops, industry
arising from natural, political, social or eral Assembly is an opportunity to be
National Allergy Societies. symposia, oral and poster presenta-
economic events or other unforeseen informed about current activities and Photography, film and audio for
Visit www.eaaci.org for more information. tions during the Congress and for 6
incidents beyond its control (force future plans, and to actively partici- event documentation and public months after the event.
majeure). Registration of a participant pate in the life of the Academy. reporting
Abstracts
implies acceptance of this condition. You will be able to access the General Technical Information
All abstracts will be listed on the EAACI The materials presented at this con- Assembly on Monday 08 June 2020 By participating in the EAACI Digital
The EAACI Digital Congress 2020
website as of Saturday, 6 June 2020. tinuing medical education activity are at 08:00 CET by logging in with your Congress 2020 the delegate under-
interface will be user-friendly and ful-
Presented abstract (except DCPD) made available for educational pur- EAACI member number and password. stands that recordings of the digital
ly responsive, allowing delegates to
texts will be published on the EAACI poses only. Please note that only members with content and the capture of images and
watch all sessions from their laptops/
Media Library and in the official EAACI voting rights (in good standing) will
Journal Allergy after the congress. EAACI Campus be able to vote. Please click here to
log into your membership profile and
Visit the EAACI Campus virtual booth settle any outstanding fees for your
Certificate of Attendance to learn more about EAACI’s activ- 2020 membership. Payment must
ities such as membership, publica- be done by Friday 05 June 2020 at
The Certificate of Attendance can be tions, EAACI Media Library and future 19:00 CET in order to gain access
downloaded after completing the del- events is available under one roof. The to the voting platform on Monday 08
egates survey, which will be sent via booth will be open throughout the en- June 2020.
email aproximmately two weeks after tire congress, and an online team will
the digital congress. be available for questions through the National Society Village
live chat during the following opening
CME Credits hours: The National Society Village is open
throughout the entire Digital Congress
The EAACI Digital Congress 2020, Satuday, 6 June, 09:00 – 17:30 CET
and features the virtual booths of our
06-08/2020 has been accredited- Sunday, 7 June, 09:00 – 17:30 CET
NAS from all over Europe. At each Eager to get the latest news on our
by the European Accreditation Coun- Monday, 8 June, 09:00 – 17:30 CET
booth you will be able to visualise
cil for Continuing Medical Education activities, events, and perspectives
brochures, watch videos, consult im-
(EACCME®) with 22 European CME Language from the EAACI Family?
portant national resources and much
credits (ECMEC®s). Each medical spe-
more. You will also have the chance
cialist should claim only those hours The official language of EAACI Digital
to interact with respective members Read our latest issue of the EAACI
of credit that he/she actually spent in Congress 2020 is English.
of the NAS through an e-mail form. Newsletter which features a glimpse
the educational activity. Click here for
We encourage you to visit this area
more information. Virtual Exhibition to learn more about your country’s
into the exciting programme of the
very own society dedicated to allergy, Digital Congress, COVID-19 viewpoints
Congress Scholarship Join us in meeting with key industry
experts, exchange knowledge on criti- asthma and immunology, or explore from our doctors and researchers
Due to the change of format, we re- cal areas of development and research developments in the field from other on the frontline, and much more!
gret to inform you that there will be in allergy and immunology. The digital countries!
Edition May 2020 available on EAACI.org
8EAACI future events EAACI future events
Focused Meetings
FAAM 2020 - Food Allergy and Anaphylaxis Meeting SAM 2021 - Skin Allergy Meeting
15-17 October 2020 / Manchester, United Kingdom 11 – 13 March 2021 / Copenhagen, Denmark
For the sixth consecutive time FAAM 2020 will be the leading event in the area of food Held in collaboration with the European Society for Contact Dermatitis (ESCD),
allergy and anaphylaxis where internationally acclaimed speakers will share their knowl- SAM 2021 will give up to date information for clinicians and cover basic, translational
edge. The meeting’s programme will bring you the most recent research, opinion and best and clinical aspects on diseases such as atopic dermatitis, contact dermatitis, occupa-
practice in the field of food allergy and anaphylaxis in children and adults, delving into the tional eczema and more. To increase the learning experience, practical courses, interac-
molecular and cellular mechanisms of food allergy and anaphylaxis, practicalities of diagno- tive workshops and case reports with an important “teaching point” will be implemented
sis and patient management and exciting new developments for prevention and treatment. in addition to keynote lectures given by experts from top-level international institutions.
EUROBAT 2020 - European Consortium on Application of Flow Allergy Schools & Master Classes
Cytometry in Allergy
15 October 2020 / Manchester, United Kingdom Allergy School on Anaphylaxis: Etiology Prevention and Management
The sessions of EUROBAT will cover the current applications of BAT in food allergy, Autumn 2020 / Izmir, Turkey
insect allergy, drug hypersensitivity, urticaria as well as future and new developments.
Each session will have invited speakers and open presentations based on abstract sub- Anaphylaxis with its life-threatening potential has always been one of the most impor-
missions. The event will also involve an interactive roundtable discussion on the topic tant emergencies for all clinicians. Therefore, it is essential to review the information we
“Globalized exchange of experiences for BAT quality assurance” with all attendees and have in order to keep up with the recent advances. In lectures and interactive workshops,
invited guests. the Allergy School will host discussions regarding the causes, initiators and co-factors of
anaphylaxis, possible preventive measures and management of anaphylaxis.
ISAF 2020 - International Severe Asthma Forum Master Class on Perioperative Hypersensitivity
22-24 October 2020 / Rome, Italy Spring 2021 / Verona, Italy
ISAF is a cutting edge and evidence-based EAACI Focused Meeting with a scientific The Master Class on Perioperative Hypersensitivity will provide a contemporary under-
programme including a broad range of session formats and designed to facilitate standing of the clinical presentation, common causes and diagnostic work-up of patients
interactive and stimulating discussions. Among key topics of the 2020 edition there referred for the investigation of perioperative hypersensitivity.
will be precision medicine, electronic-health, big data, microbiome, pharmacogenomics, The event’s faculty will focus on the importance of collaboration
medical devices, breathomics and regulatory aspects. between allergists/immunologists and anaesthesiologists
Special relevance will be also given to severe asthma in children and during pregnancy. and will include absolute experts in the field
presenting the latest evidence and
their own practical experiences.
DHM 2021 - Drug Hypersensitivity Meeting Due to COVID-19,
Spring 2021 / Verona, Italy
some of our event dates
and formats might be
The EAACI Drug Hypersensitivity Meeting (DHM 2021) taking place in Spring 2021, subject to change.
in Verona, Italy, is an interdisciplinary meeting, bringing together researchers and More 2021 events
physicians from different disciplines. It is the leading event of its kind, attracting up to
600 physicians and researchers from all over the world.
will be announced
shortly.
10 1112 13
Ceremonies
Welcome Ceremony
At the kick-off our EAACI 2020 Digital Congress tune in to three top-level Opening Keynote lectures under the theme of
“Solutions and Challenges in Modern Medicine”. Explore present-day findings in relation to the COVID-19 pandemic and our field,
and listen to Sir Gregory Winter, Nobel Prize Winner for Biochemistry address the way forward for biologicals in modern medicine.
In addition to these stimulating sessions, get the virtual feel of an exciting congress to come through welcome talks by our EAACI
President and EAACI Congress Chair, and find out who these year’s recipients of our prestigious EAACI Awards are.
Closing Ceremony
At the close of our first digital Congress, we already look forward to the next opportunity for our community to meet in Madrid
for the EAACI Congress 2021. The closing ceremony will give you a glimpse into its preparations, theme and programme through
addresses from our 2021 Local Organising Committee. In addition, our EAACI President and Congress Chair 2020 take this
opportunity to thank all participants and look back to this Congress’ successes and highlights.
Fellowship Winners
Name Country Name Country
Clinical Fellowships Research Fellowships
(3 months duration) Short-term Research Fellowships
(3 months duration)
Mattia Giovannini United Kingdom
Christos Fokoloros Germany Gustavo Jorge Molina Belgium
Huyen Thanh Thuc France Kristin Boykova Boteva Germany
Carina Petricau United Kingdom Mario Lovric Denmark
Johnson Nameirakpam Italy Sandip D Kamath Austria
Deniz Eyice Karabacak Austria
Fatma Esra Gunaydin United Kingdom Medium-term Research Fellowships
(6 months duration)
Jialing Jiang United Kingdom
Angelika Tscheppe Belgium
Amri Manel Denmark
Long-term Research Fellowships
(12 months duration)
Ruben Fernandez Santamaria Switzerland
Didem Sanver Akbas United Kingdom
Carole Florence Guillet United Kingdom
Karolina Dumycz Germany
14 15EAACI Fellows EAACI Awards 2020
EAACI recognizes excellence in basic and clinical research in the field of allergy and clinical immunology and awards the title of Each year, EAACI honours European researchers and clinicians who have contributed significantly to the development of inno-
EAACI Fellow to EAACI members who have excelled in their field. EAACI fellows will form an elite advisory board that will be called vative diagnostic and therapeutic strategies for control and prevention of allergic diseases, to the understanding of their patho-
upon by the Academy on various matters in future years. physiology and to the strengthening of allergology as a specialty in Europe. The EAACI Awards 2020 will be presented during
the Opening Ceremony - Saturday, 6 June 2020 at 19:45 CET.
Paul Ehrlich Award for Experimental Research 2020 - Mübeccel Akdis
Dr Akdis graduated from the Medical faculty of Uludag University, Bursa-Turkey in
1985. She is working at the Swiss Institute of Allergy and Asthma Research (SIAF)
since 1995 and received her PhD in Immunology. Dr Akdis worked as a postdoc-
toral scientist and became a group leader at SIAF, where she has established her
own research group in 2003. Dr Akdis made her habilitation (Venia Legendi) at the
Zurich University Medical Faculty on Experimental Immunology in 2005 and be-
came a professor in 2015. She has published more than 231 Peer-reviewed arti-
cles, Sum of times cited: 18’580 and her h-index: 74 (90-Google scholar).
Her major research contributions are on mechanisms of allergen tolerance, high
dose allergen exposure models in humans, mechanisms of allergen-specific im-
Claudia Traidl – Hoffmann Giorgio Walter Canonica munotherapy, functions of T regulatory cells, NK regulatory cells and recently IL-
EAACI Fellow for Clinical Research EAACI Fellow for Clinical Research 10 producing human B regulatory cells. Demonstration of immunological effects
of rhinoviruses on T and B cells and breaking of immune tolerance to allergens,
Dr. Canonica has been awarded the FEAACI in 2020 for Demonstration of an angiogenesis promoting novel B cell subset. She has received
Dr. Traidl-Hoffmann has been awarded the FEAACI in
his continuous excellence in investigating the different research grants and collaborative grants from the Swiss National Foundation, Eu-
2020 for her continuous excellence on environment-hu-
T Iymphocytes subsets and their functional role in basic ropean Union and Sean Parker Seed Grant. She received numerous awards, includ-
man and environment-environment interaction with a fo-
and clinical research (Allergy, Organ specific autoimmun- ing Ferdinand Wortman Prize, Professor Hans Storck Award, Sedat Simavi Medicine
cus on the barrier function of border surfaces, and the
ity, CNS degenerative diseases and cancer), and the mo- Award, International Distinguished Fellow Award of the American College of Allergy,
effects of climate change on environment and health.
lecular events and interactions between immunocompe- Asthma & Immunology (ACAAI), 2018. She is a board member of the World Allergy
tent cells. Organization (WAO) and has taken active roles in the organization of several EAACI
Davos, Immunology Winter Schools and all the World Immune Regulation Meetings
(WIRM) since their initiation in 2007.
Charles Blackley Award for the Promotion of the Specialty 2020 -
José María Olaguibel
Jose Mª. Olaguibel is active in clinical allergy practice, teaching (Clinical Assistant
Professor of Medicine, Universidad de Navarra), and clinical research (Navarrabi-
omed.es), with a special interest in respiratory allergy, including lung function and
airway inflammation, asthma diagnosis, and immunotherapy with allergens. He has
produced more than 100 original articles published in international scientific jour-
nals (H index 28). He is a member of the American Academy of Asthma, Allergy and
Nikolaos Papadopoulos Sebastian Johnston Clinical Immunology, the European Academy of Allergy and Clinical Immunology and
EAACI Fellow for Research EAACI Fellow for Research the Spanish Society of Allergy and Clinical Immunology (Past President). By now, he
Dr. Papadopoulos has been awarded the FEAACI in 2020 Dr. Johnston has been awarded the FEAACI in 2020 is the Editor in Chief of the Journal of Investigational Allergology and Clinical Immu-
for his continuous excellence in understanding of the role for his continuous excellence in addressing the mecha- nology (FI: 3,8), and has been recently involved in the development of the Spanish
on infections in asthma, and basic, translational and clin- nisms of acute exacerbations of asthma and interactions guidelines for asthma diagnosis and management (GEMA 5.0).
ical aspects of allergy, from molecule characterisation to between respiratory infections and allergic disease, and
clinical trials. development of human and mouse in vivo models of
rhinovirus.
16 17EAACI Awards 2020 EAACI Awards 2020
Each year, EAACI honours European researchers and clinicians who have contributed significantly to the development of inno- Each year, EAACI honours European researchers and clinicians who have contributed significantly to the development of inno-
vative diagnostic and therapeutic strategies for control and prevention of allergic diseases, to the understanding of their patho- vative diagnostic and therapeutic strategies for control and prevention of allergic diseases, to the understanding of their patho-
physiology and to the strengthening of allergology as a specialty in Europe. The EAACI Awards 2020 will be presented during physiology and to the strengthening of allergology as a specialty in Europe. The EAACI Awards 2020 will be presented during
the Opening Ceremony - Saturday, 6 June 2020 at 19:45 CET. the Opening Ceremony - Saturday, 6 June 2020 at 19:45 CET.
PhARF Award 2020 – Paul Turner
Daniel Bovet Award for Treatment and Prevention 2020 – George du Toit Dr Paul Turner is a Clinician Scientist and Honorary Consultant in Paediatric Allergy
& Immunology at Imperial College London, and Clinical Associate Professor at the
George du Toit is Professor of Paediatric Allergy, Evelina London Children’s Hospi- University of Sydney, Australia. His research focusses on the pathophysiology of se-
tal, Guy’s and St Thomas’ NHS Trust and Kings College London. George is active in vere allergic reactions to food, and how this impacts upon allergen risk management
clinic research currently focusing on the LEAP-Trio and EAT-On food allergy preven- and the use of precautionary allergen labelling. He leads the food allergy desensi-
tion studies, the BAT II diagnostic study, and oral and epicutaneous peanut desen- tisation programme at St Mary’s Hospital, London; the team was awarded the Best
sitisation trials. George is lead clinician for the Children’s Drug Allergy service at UK Clinical Team by Allergy UK in 2018. Paul’s research is funded by the Medical
Evelina London Children’s Hospital and past Chairperson of the European Academy Research Council, FSA, European Commission, NIHR and EAT Foundation (USA). He
of Allergy and Clinical Immunology (EAACI) Paediatric Section. is a visiting Honorary Consultant at a number Central London Hospitals, a paediatric
consultant on allergy-related issues to Public Health England, and current Chair of
the BSACI Paediatric Allergy Group and the WAO Anaphylaxis Committee. He is a
member of the UK Food Standards Agency’s Science Council.
Allergopharma Award – Rodrigo Jimenez Saiz
Clemens von Pirquet Award for Clinical Research 2020 - Santiago Quirce Rodrigo Jiménez-Saiz is a Junior Group Leader at the Dept. of Immunology and
Oncology at the National Center for Biotechnology (CNB-CSIC, Madrid, Spain) and
Santiago Quirce is Head of the Allergy Department at La Paz University Hospital, a part-time Assistant Professor at the Dept. of Pathology and Molecular Medicine
Professor of Respiratory Medicine at Universidad Autónoma of Madrid, and Director (McMaster University, Hamilton, Canada). He is also a part-time Teaching Professor
of the Research group on Allergic diseases at La Paz Institute for Health Research of Biomedicine at the Universidad Francisco de Vitoria (Madrid, Spain) and a Visiting
(IdiPAZ), Madrid, Spain. He graduated in Medicine from the University of Santander Researcher at the Spanish National Center for Cardiovascular Research (CNIC, Ma-
and obtained his Ph.D. degree at the University of Cantabria, Spain, and received drid, Spain). The Jiménez-Saiz Lab aims to understand immunological principles of
the Distinguished Alumni Award from this University in 2014. He did his post- Th2 immunity in the context of allergic disease, particularly as it pertains to acute
graduate training as Research Fellow at Vancouver General Hospital, Respiratory allergic reactions (anaphylaxis) and its modulation by the microbiota, the mainte-
Division, University of British Columbia, Canada. Dr. Quirce has edited and authored nance of IgE immunity (memory responses), and the impact of allergic disease in the
numerous publications, including 12 books and over 400 peer-reviewed papers. development of other pathologies. Rodrigo Jiménez-Saiz is an elected member of
He has been a member of the Executive Committee of EAACI as representative of the Immunology Section of EAACI, Chair of a EAACI Task Force on public outreach
the Interest Groups, and Secretary of the Spanish Society of Allergy and Clinical and member of the Scientific Committee of FAAM 2020. He serves on a number
Immunology. of Editorial Boards including Allergy, International Archives of Allergy and Immu-
nology, and Frontiers in Allergy, and was recently nominated Top Peer Reviewer in
Immunology by Publons.
18 19EAACI Activity Challenge Description of Session Types
Overview Company Sponsored Symposia Interactive Symposia (ISYM) and Late-Breaking Thematic Poster
Workshops (IWS) Sessions (LB TPS)
The Digital congress delegates will be able to earn points at several Industry Symposia will run in parallel
check points and interactions along the way during the EAACI Digital with the main scientific programme on Interactive Workshops are sessions LB TPS can be found in the e-poster
Congress 2020 experience. the digital programme. These sympo- in which speakers share and discuss section of the Digital Congress, to-
sia are organised independently by the evidence and experience gathered gether with a voice-over, and available
sponsoring companies who also select - clinical and/or basic - in a certain in the EAACI Media Library.
Available to all registered delegates during their visit to the virtual
the topics and speakers which are ap- field. These sessions are interactive,
exhibition area when visiting, chatting, answering scientific questions, and proved by the Scientific Programme
providing valuable feedback to our industry partners. and the speaker addresses some fre- Oral Abstract Sessions (OAS)
Committee. quently asked questions with regards
to the topic.
Additionally, with the Leaderboard function, delegates will be able to see Digital Congress Poster Display The most exciting work from abstracts
the live scores of the top 20 delegates. (DCPD) submitted to the congress will be hon-
Interactive Postgraduate Courses oured with a place in these sessions.
EAACI would like to thank our Industry Sponsors for their support and Digital Congress Poster Display (for- (IPGC) Each presenter highlights her/his
dedication during these difficult times, this could not be done without the mer On-Site Poster Display) can be work.
Interactive Postgraduate Courses are
valuable contributions from them. found in the e-poster section of the
educational sessions where the speak-
Digital Congress. DCPD will not be Poster Discussion Sessions (PDS)
er addresses some frequently asked
The digital information exchange at EAACI 2020 represents a new published in the EAACI Media Library
questions with regards to the topic.
and exciting experience for us all. We encourage you to explore it all! and the official journal of EAACI after PDS can be found in the e-poster sec-
the Congress. tion of the Digital Congress, together
Use your well-deserved breaks to network, inform and exchange. Keynote Symposia (KL)
with a voice-over, and available in the
Ethics Session (ES) Keynote Symposia are the core of the EAACI Media Library.
congress activities. These are exhaus-
How does it work? Ethics Session is a state of the art
tive reviews of a major subject of the Pro & Cons (P&C)
symposium in which the speakers crit-
specialty, addressed to all congress
• Once you have logged on to the EAACI 2020 Platform, the Activity challenge will appear on the Home Page. ically review ethical aspects of topics The Pro & Con Sessions allow speak-
participants. Plenary Symposia are
Click on the Activity Challenge icon which will prompt a description of the activities. related to Allergy and Clinical Immu- ers to debate controversial topics in
scheduled at “prime times” in the pro-
nology. The target audience consists an attractive format which provides
gramme, with no crossover with other
• Goal is to generate as many points as possible from the group of activities listed. of delegates who are primarily inter- “food for thought”. The Pro & Con Ses-
activities to enable maximum attend-
ested in the subject or wish to update sions will be available in the Recorded
ance.
their knowledge in the area. The Ethics Scientific Programme only.
• Each activity will have a maximum amount of points that can be achieved, which will be distributed based on how much the
Session will be available in the Record-
attendee has completed. Late-Breaking Oral Abstract
ed Scientific Programme only.
Sessions (LB OAS) Sister Society Symposia (SSS)
• As activities progresses, there are barriers that shows:
Hot Topics (HT) EAACI has collaborated with a number
- Activity completion status. Eg. You have completed 5/10 activities The most exciting work from late-breaking
of sister societies to develop sympo-
- Participants point total can be seen next to their profile. Hot Topic Sessions consist of pres- abstracts submitted to the congress
sia that represent regional or scientific
entations. Topics are selected close will be honoured with a place in these
areas common to EAACI and the sis-
• In the case of multiple participants in the EAACI Activity Challenge tied with the most points on the overall points table, to the time of the congress, with the sessions. Each presenter highlights
ter society. This is a chance to expand
the winner will be automatically be identified based on the submission time of first completing the full Activity Challenge. goal of presenting new and exciting their work.
your knowledge beyond the traditional
data in a more informal format than boundaries. There will be 6 live SSS
a typical session. Hot Topic Sessions Late-Breaking Poster Discussion and the remaining ones will be avail-
allow members to gain insight into the Sessions (LB PDS) able in the Recorded Scientific Pro-
latest news and findings in allergy and gramme only.
clinical immunology. LB PDS can be found in the e-poster
section of the Digital Congress, to-
gether with a voice-over, and available
in the EAACI Media Library.
20 21Description of Session Types Programme at a Glance
Saturday, 6 June 2020
Symposia (SYM) Thematic Poster Sessions (TPS) Important Notice
This page gives an overview of the digital sessions organised on June 6, 2020.
Symposia are state-of-the-art educa- TPS can be found in the e-poster sec- Due to the change of format, we re- The original scientific programme created for the EAACI Congress 2020 in London Recorded Scientific
tional sessions in which the speakers tion of the Digital Congress, together gret to inform you that the following includes much more content. It is possible to access this “Recorded Scientific Programme
critically review diverse aspects of with a voice over, and available in the sessions will not be part of the EAACI Progamme” by clicking on the link button on the right.
a specific topic. The target audience EAACI Media Library. 2020 Digital Congress:
consists of delegates who are primar- • Allied Health Day
ily interested in the subject or wish to Year in Review (YIR) • Business Meetings (BM)
update their knowledge in the area. • Company Sponsored Mini Symposia
CET Track 1 Track 2
There will be 9 live SYM and the re- The Year in Review Sessions are com- (CSMS) Time Live Scientific Programme Industry Programme
maining ones will be available in the plete and authoritative, focused on the • Clinical Village
Recorded Scientific Programme only. highlights published during the previ- • EAACI Immunology Course
ous year on a specific topic. • Learning Lounges (LL) 09:00
• Satellite Symposia (SAT) 09:15 09:00 - 10:25 CET
09:30 KS 1 - Keynote Symposia
09:45 The challenges of severe Asthma
10:00
10:15
10:30 Digital break
10:45
10:30 - 11:45 CET
11:00 CSS 1 - Company Sponsored Symposia
10:45 - 12:15 CET
11:15 SYM 1 - Symposia
11:30 Novel insights into the development of allergic disease
11:45
12:00
12:15
Digital break 12:00 - 13:15 CET
12:30 CSS 2 - Company Sponsored Symposia
12:45
13:00 12:45 - 14:15 CET
13:15 SYM 2 - Symposia
13:30 Food Allergy: prevention is better than cure
13:45
13:30 - 14:45 CET
14:00 CSS 3 - Company Sponsored Symposia
14:15
Digital break
14:30
14:45
15:00 14:45 - 16:15 CET
15:15 SYM 3 - Symposia
15:30 Biologicals and other therapies in allergy:
15:45 from clinical trials to clinical practice
16:00
16:15
Digital break
16:30
16:45
16:45 - 17:45 CET 16:30 - 17:45 CET
17:00 SSS 1 - Sister Society Symposium CSS 5 - Company Sponsored Symposia
17:15 EAACI - NIAID/NIH Joint Symposium: from bed to bench side
17:30
17:45
Digital break
18:00
18:15
18:15 - 19:15 CET
18:30 SSS 2 - Sister Society Symposium
18:45 EAACI - ACAAI joint symposium: atopic dermatitis: what’s new?
19:00
19:15
19:30 Digital break
19:45
20:00 19:50 - 20:00 CET Welcome Ceremony
20:15
20:30 20:00 - 21:00 CET Opening Keynote Lectures
20:45 21:00 - 21:15 CET EAACI Awards
21:00
21:15
22 23Programme description Programme description
Saturday, 6 June 2020 Saturday, 6 June 2020
KS 1 The challenges of severe asthma SYM 01 Novel insights into the development SYM 02 Food allergy: prevention is better than cure SYM 03 Biologicals and other therapies in allergy:
Saturday, 6 June 2020 - 09:00-10:25 CET of allergic disease Saturday, 6 June 2020 - 12:45-14:15 CET from clinical trials to clinical practice
Saturday, 6 June 2020 - 10:45-12:15 CET Saturday, 6 June 2020 - 14:45-16:15 CET
Learning objectives: Learning objectives:
• To discuss the role of microbiome in allergy and asthma. Learning objectives: • To provide an update on current strategies of prevention Learning objectives:
• To discuss the role of exposome and asthma. • To discuss the properties of allergen and their role in of food allergy. • To discuss and give evidence of anti-TSLP in severe
• To discuss the utility of machine learning and algorithms allergy sensitization. • To gain insight into issues that families have to uncontrolled asthma.
in asthma management. • To discuss novel insights into development of allergic implement these recommendations. • To discuss and give evidence of anti-IL4Ra in atopic
• To discuss factors that influence asthma development diseases. • To discuss therapeutic approaches to prevent food dermatitis.
from childhood to adulthood. • To discuss and outline the role of the epithelium in allergy derived from weaning products. • To discuss and give evidence of anti-IgE in chronic
allergic diseases. • To discuss the role of gut microbiota in development of spontaneous urticaria.
Chairs • To discuss the impact of multiple stressors through food allergy and the use of synbiotics in the management • To discuss interferon therapy as an asthma preventative
Matteo Bonini (Italy), Liam O’Mahony (Ireland) different environmental pathways and their impact of food allergy. treatment approach.
on Allergy. • To discuss the dietary and psychological issues observed • To discuss novel developments in biosimilars and drug
The airway microbiome in asthma development - Q&A • To discuss the impact of pollution on allergic diseases in the allergy clinic related early to food introductions. development in Allergy.
Benjamin Marsland (Australia) and outline call for actions.
Prevention of food allergy: where are we now? Tezepelumab (anti-TSLP) in asthma
Exposomes and gene interaction in asthma - Q&A How do allergens sensitize? Gideon Lack (United Kingdom) Jonathan Corren (United States)
Kian Fan Chung (United Kingdom) Barbara Bohle (Austria)
Challenges on the implementation of early introduction Dupilumab (anti-IL4Ra) in CRSwNP
Trajectory of lung disease from childhood Novel insight into development of allergic diseases of allergenic foods Claus Bachert (Belgium)
to adulthood - Q&A Jean Bousquet (France) Edmond S. Chan (Canada)
Patrick Holt (Australia) Ligelizumab (anti-IgE) in chronic spontaneous
Epithelial cell barrier and allergic diseases Over-the-counter allergy prevention weaning urticaria
Big data and cluster analysis: a real life Cezmi Akdis (Switzerland) products Marcus Maurer (Germany)
perspective - Q&A Michael Perkin (United Kingdom)
Ioana Octavia Agache (Romania) Lifelong exposure to multiple stressors through Interferon therapy and novel biologicals
different environmental pathways and their impact Latest developments in pre, pro and symbiotics in food Sebastian Lennox Johnston (United Kingdom)
Launch of the Biological guidelines - Q&A on allergy allergy prevention
Ioana Octavia Agache (Romania) Isabella Annesi-Maesano (France) Nikolaos Papadopoulos (Greece) Upcoming drug developments and biosimilars
Marek Jutel (Poland) Matteo Bonini (Italy)
Oscar Palomares (Spain) Air pollution and allergy: call for action! Dietary and psychological issues related to food
Stephen Holgate (United Kingdom) introductions Q&A
Carina Venter (United States)
Q&A
Q&A
24 25Programme description
Saturday, 6 June 2020
FAAM 2020
15 – 17 October 2020
SSS 01 EAACI - NIAID/NIH Joint Symposium:
From bench to bedside: Potential therapeutics for
SSS 02 EAACI – ACAAI joint symposium:
Atopic dermatitis: what’s new?
Manchester, United Kingdom
allergic diseases from the NIAID-supported Asthma Saturday, 6 June 2020 - 18:15-19:15 CET
and Allergic Diseases Cooperative Research Centers
Saturday, 6 June 2020 - 16:45-17:45 CET Learning objectives: Food Allergy and Anaphylaxis Meeting
• To discuss how to use the atopic Dermatitis Yardstick in
Learning objectives: the clinic.
• To discuss how to target Rhinovirus for asthma prevention. • To discuss how to manage atopic dermatitis.
• To discuss the utility of Glucagon-like-1 receptor agonist • To describe the novel therapeutic approaches in atopic
in asthma. dermatitis.
• To describe the therapeutic opportunities of Siglecs.
Using the “atopic dermatitis yardstick” in clinical practice
Targeting rhinovirus infection as a strategy for asthma James L Sublett (United States)
prevention and treatment
James E Gern (United States) Managing quality of life and comorbidity issues in
atopic dermatitis
Glucagon-like 1 receptor agonists: repurposing for asthma? Michael S. Blaiss (United States)
Ray Stokes Peebles, Jr. (United States)
JAK inhibitors and monoclonals: the future of atopic
Siglecs on eosinophils and mast cells: from biology to dermatitis management
therapeutic opportunities Luz Fonacier (United States)
Bruce Scott Bochner (United States)
Q&A
Q&A
Welcome Ceremony
Saturday, 6 June 2020 - 19:50-20:00 CET
OKS 1 The EAACI Congress 2020 opening Keynote Symposia: Solutions and challenges in modern medicine
Saturday, 6 June 2020 - 20:00-21:00 CET
Learning objectives:
• To describe the journey of biologicals in modern medicine.
• To described and outline the impact of COVID-19 in health and respiratory airway disease.
• Immune modulation strategy in the management of COVID-19.
Chairs
Mohamed Shamji (United Kingdom), Marek Jutel (Poland)
Paving the way for biologicals in modern medicine (The Nobel Laureate Keynote Lecture)
Gregory Winter (United Kingdom)
Corona virus and lung inflammation - the current pandemic
Peter Openshaw (United Kingdom)
Immune modulation in the era of COVID19
Marek Jutel (Poland)
EAACI Awards
Saturday, 6 June 2020 - 21:00-21:15 CET
www.eaaci.org
26Programme at a Glance Programme description
Sunday, 7 June 2020 Sunday, 7 June 2020
This page gives an overview of the digital sessions organised on June 7, 2020. KS 2 Novel insights into Immunotherapy approaches SSS 03 EAACI - APAAACI joint symposium:
The original scientific programme created for the EAACI Congress 2020 in London Recorded Scientific for food and aeroallergens Allergies in asia pacific: insights and lessons learnt
includes much more content. It is possible to access this “Recorded Scientific Programme Sunday, 7 June 2020 - 09:00-10:20 CET east versus west
Progamme” by clicking on the link button on the right. Sunday, 7 June 2020 - 10:45-11:45 CET
Learning objectives:
• To describe endotypes of upper airway disease and Learning objectives:
CET Track 1 Track 2 discuss the clinical effectiveness of novel biologics that • To describe house dust mite allergy in Asia Pacific.
target endotypes. • To highlight aspects of allergic diseases in Asia Pacific
Time Live Scientific Programme Industry Programme • To describe new emerging approaches in immunotherapy and the similarities and differences between east and
for inhalant allergens. west, specifically lifestyles, cultural and socio-economics,
• To discuss the utility of artificial intelligence (machine as well as changing environments and lifestyles and
09:00 learning) in biomarker discovery for immunotherapy. growing economies.
09:15 09:00 - 10:20 CET • To discuss the burden and consensus on urticaria
09:30 KS 2 - Keynote Symposia
Novel insights into Immunotherapy approaches for food Chairs management in Asia Pacific.
09:45
10:00 and aeroallergens Cezmi Akdis (Switzerland), Stephen R Durham (United Kingdom)
10:15 House dust mite allergy in Asia Pacific
10:30 Digital break Immunotherapy for food allergy: is tolerance too much Jiu-Yao Wang (Taiwan)
10:45 10:45 - 11:45 CET of an expectation? - Q&A
10:30 - 11:45 CET
11:00 SSS 3 - Sister Society Symposium
11:15 EAACI - APAAACI joint symposium: allergies in asia pacific:
CSS 7 - Company Sponsored Symposia George du Toit (United Kingdom) Climate change and air pollution in Asia Pacific and
11:30 insights and lessons learnt east versus west impact on respiratory allergy
11:45 Mechanisms of Oral, SLIT and other approaches of food Ruby Pawankar (Japan)
Digital break
12:00 immunotherapy - Q&A
12:15
12:00 - 13:15 CET Wayne G Shreffler (United States) Burden and consensus on urticaria management
12:30 12:15 - 13:45 CET CSS 8 - Company Sponsored Symposia
12:45 in Asia Pacific
SYM 4 - Symposia
13:00 Utility of OMICs: a roadmap to precision medicine B cell tolerance: an essential mechanism for allergen Amir Hamzah Abdul Latiff (Malaysia)
13:15 immunotherapy in house dust mite allergy - Q&A
13:30 13:30 - 14:00 CET
CSS 9 - Company Sponsored Symposia
Mübeccel Akdis (Switzerland) Q&A
13:45
Digital break
14:00
14:15 Artificial intelligence approach to understanding
14:15 - 15:15 CET
14:30
SSS 4 - Sister Society Symposium the mechanisms and biomarker discovery for allergen
14:45 EAACI - ERS joint symposium: asthma for the roaring 20-twenties immunotherapy - Q&A
15:00
15:15
Mohamed Shamji (United Kingdom)
Digital break 15:00 - 16:15 CET
15:30 CSS 10 - Company Sponsored Symposia
15:45
16:00
15:45-17:15 CET
16:15 SYM 5 - Symposia
16:30 Insights into the management of drug allergy
16:45
16:30 - 17:45 CET
17:00 CSS 11 - Company Sponsored Symposia
17:15
Digital break
17:30
17:45
18:00
17:45-19:15 CET
18:15 SYM 6 - Symposia 18:00 - 19:15 CET
18:30 Novel mechanisms in united severe united airway disease CSS 12 - Company Sponsored Symposia
18:45
19:00
19:15
19:30
19:45
20:00
20:15
20:30
20:45
21:00
21:15
28 29Programme description Programme description
Sunday, 7 June 2020 Sunday, 7 June 2020
SYM 04 Utility of OMICs: a roadmap to precision medicine SSS 04 EAACI - ERS joint symposium: SYM 05 Insights into the management of drug allergy SYM 06 Novel mechanisms in united severe
Sunday, 7 June 2020 - 12:15-13:45 CET Asthma for the roaring 20-twenties Sunday, 7 June 2020 - 15:45-17:15 CET airway disease
Sunday, 7 June 2020 - 14:15-15:15 CET Sunday, 7 June 2020 - 17:45-19:15 CET
Learning objectives: Learning objectives:
• To discuss the novel computational models and current Learning Objectives: • To describe the differences in management of NSAID Learning objectives:
challenges. • To provide an update on the big changes in asthma hypersensitivity in children and adults. • To describe the relationship between Inflammatory
• To discuss the OMICs data integration in allergy. treatment: GINA 2019. • To discuss the management of drug reactions in a Endotypes and Clinical Presentations in Chronic
• To describe novel approaches to visualize and track • To discuss the role of personalized medicine in severe perioperative setting. Rhinosinusitis.
tissue inflammation. asthma in low- and middle-income countries. • To discuss the management of drug reactions in a • To describe novel insights in innate lymphoid cells in
• To outline the advantages and disadvantages of • To describe novel approaches to childhood asthma. perioperative setting. upper and lower airway disease and how they can be
untargeted and targeted metabolomics in phenotyping • To describe the management of adverse reactions to exploited for therapeutic use.
allergic diseases novel approaches to visualize and track Big changes in asthma treatment : GINA 2019 biologics. • To discuss the pathogenic and protective role of B cells in
tissue inflammation. Luis Pérez de Llano (Spain) Chronic Rhinosinusitis.
• The utility of system biology approaches to advance NSAID hypersensitivity of children vs adults • To discuss recent advances in genomics in severe airway
clinical patient care. Tailored therapy in severe asthma: is it a dream in Marina Atanaskovic-Markovic (Serbia) disease.
low- and middle-income countries? • To describe and discuss the clinical effectiveness of novel
Human and computational models of immune mediated Arzu Yorgancioglu (Turkey) Drug reactions in the perioperative setting biologics that target endotypes.
inflammatory skin disease: challenges, insights and Lene Heise Garvey (Denmark)
perspectives A system biology and machine learning approach Associations between inflammatory endotypes and
Nick Reynolds (United Kingdom) to childhood asthma Early biomarkers for severe drug hypersensitivity clinical presentations in chronic rhinosinusitis
Adnan Custovic (United Kingdom) reactions Atsushi Kato (United States)
Integrative OMICs data analysis reveals key drivers Maria J Torres (Spain)
of peanut allergic reactions Q&A Targeting innate lymphoid cells in lower and upper
Kari Christine Nadeau (United States) Management of adverse reactions to biologics airway disease: what’s new?
Mariana Castells (United States) Hideaki Morita (Japan)
Utility of single-cell RNA sequencing to identify
distinct gene signature in airway Th2 cells Utility of provocation tests before deciding to desensitize B cells in in chronic rhinosinusitis: friend or foe
Jonathan Coquet (Sweden) Jean-Christoph Caubet (Switzerland) Anju Tripathi Peters (United States)
Utility of untargeted and targeted metabolomic Q&A Advances in genomics in severe airway disease
approaches in phenotyping allergic diseases Sanna Toppila-Salmi (Finland)
Domingo Barber (Spain)
Novel therapeutic approaches targeting endotypes
Integrated systems biology strategies for diagnostics of severe airway disease
and immune monitoring in allergy Philippe Gevaert (Belgium)
Markus Ollert (Luxembourg)
Q&A
Q&A
30 31You can also read
